Form 4 for LGVN Longeveron Inc.
Accepted 2023-08-02 00:00:00 ET · period of report 2023-07-24 · accession 0001214659-23-010670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-02 | 2023-07-24 | LGVN | Agafonova Nataliya | Chief Medical Off | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-24 | A | A | 30,000 | $0.00 | 30,000 | D | — | — | (F1) Represents the award of 30,000 Restricted Stock Units, which vest 25% on each of the award date, October 1, 2023, January 1, 2024, and April 1, 2024. (F2) Includes 22,500 Restricted Stock Units. |